Cupid Ltd
Established in 1993, CUPID Limited is India's premier manufacturer of male and female condoms, personal lubricant, and IVD kits.[1]
- Market Cap ₹ 2,728 Cr.
- Current Price ₹ 101
- High / Low ₹ 114 / 50.0
- Stock P/E 66.6
- Book Value ₹ 12.8
- Dividend Yield 0.00 %
- ROCE 16.9 %
- ROE 12.7 %
- Face Value ₹ 1.00
Pros
- Company is almost debt free.
Cons
- Stock is trading at 7.95 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoters have pledged 40.5% of their holding.
- Debtor days have increased from 93.9 to 120 days.
- Working capital days have increased from 203 days to 370 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
20 | 44 | 61 | 84 | 81 | 85 | 160 | 143 | 133 | 159 | 171 | 203 | |
17 | 32 | 36 | 50 | 53 | 65 | 108 | 107 | 109 | 118 | 121 | 142 | |
Operating Profit | 2 | 13 | 25 | 34 | 27 | 21 | 52 | 36 | 23 | 41 | 50 | 61 |
OPM % | 10% | 29% | 41% | 41% | 34% | 24% | 33% | 25% | 17% | 26% | 29% | 30% |
0 | 1 | 2 | 1 | 1 | 2 | 3 | 5 | 4 | 5 | 7 | 0 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 2 | 2 |
Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 4 |
Profit before tax | 0 | 11 | 25 | 32 | 26 | 21 | 53 | 38 | 25 | 42 | 53 | 55 |
Tax % | 60% | 33% | 36% | 37% | 34% | 27% | 24% | 24% | 30% | 25% | 24% | 25% |
0 | 8 | 16 | 21 | 17 | 15 | 40 | 29 | 17 | 32 | 40 | 41 | |
EPS in Rs | 0.00 | 0.29 | 0.60 | 0.77 | 0.64 | 0.57 | 1.49 | 1.09 | 0.65 | 1.18 | 1.49 | 1.52 |
Dividend Payout % | 0% | 22% | 21% | 22% | 29% | 35% | 15% | 21% | 35% | 21% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | 16% |
5 Years: | 5% |
3 Years: | 15% |
TTM: | 19% |
Compounded Profit Growth | |
---|---|
10 Years: | 18% |
5 Years: | 1% |
3 Years: | 35% |
TTM: | 6% |
Stock Price CAGR | |
---|---|
10 Years: | 42% |
5 Years: | 63% |
3 Years: | 109% |
1 Year: | 6% |
Return on Equity | |
---|---|
10 Years: | 21% |
5 Years: | 16% |
3 Years: | 16% |
Last Year: | 13% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 11 | 11 | 11 | 11 | 11 | 13 | 13 | 13 | 13 | 13 | 13 | 27 |
Reserves | 7 | 13 | 25 | 43 | 55 | 63 | 90 | 118 | 129 | 154 | 288 | 315 |
3 | 2 | 1 | 0 | 2 | 2 | 31 | 0 | 9 | 6 | 12 | 19 | |
5 | 8 | 14 | 9 | 10 | 15 | 30 | 22 | 23 | 16 | 7 | 11 | |
Total Liabilities | 27 | 35 | 51 | 63 | 78 | 93 | 165 | 152 | 174 | 189 | 320 | 372 |
16 | 16 | 16 | 16 | 16 | 21 | 26 | 29 | 31 | 36 | 58 | 67 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 1 | 6 | 0 | 0 | 6 |
Investments | 0 | 0 | 0 | 5 | 18 | 22 | 21 | 48 | 54 | 69 | 135 | 103 |
10 | 19 | 35 | 42 | 44 | 50 | 114 | 74 | 84 | 83 | 126 | 196 | |
Total Assets | 27 | 35 | 51 | 63 | 78 | 93 | 165 | 152 | 174 | 189 | 320 | 372 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-0 | 7 | 13 | 20 | 3 | 18 | 19 | 42 | 10 | 33 | 8 | -11 | |
-0 | -1 | -1 | -5 | -9 | -14 | -37 | -9 | -13 | -22 | -80 | 45 | |
1 | -3 | -6 | -4 | -3 | -5 | 16 | -33 | 3 | -11 | 99 | -1 | |
Net Cash Flow | 0 | 3 | 6 | 11 | -9 | -0 | -2 | 0 | -1 | -0 | 27 | 32 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 59 | 67 | 79 | 59 | 100 | 97 | 95 | 65 | 84 | 59 | 102 | 120 |
Inventory Days | 165 | 155 | 60 | 133 | 259 | 168 | 437 | 230 | 197 | 229 | 184 | 226 |
Days Payable | 81 | 84 | 27 | 80 | 162 | 135 | 579 | 168 | 134 | 105 | 1 | 7 |
Cash Conversion Cycle | 144 | 139 | 112 | 112 | 198 | 130 | -46 | 127 | 147 | 183 | 286 | 340 |
Working Capital Days | 120 | 76 | 82 | 67 | 140 | 118 | 111 | 87 | 111 | 91 | 149 | 370 |
ROCE % | 3% | 48% | 79% | 72% | 43% | 29% | 50% | 28% | 17% | 26% | 22% | 17% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
23 May - Cupid Limited is hereby informing BSE about newspaper clippings of audited financial results for quarter and year ended 31st March, 2025.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
21 May - Cupid Limited reports Q4 FY25 income Rs. 61.11 Cr, FY25 income Rs. 203.18 Cr, PAT Rs. 40.89 Cr, expansion underway.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
21 May - Cupid Limited is hereby informing BSE about Investor Presentation.
-
Financial Results For Quarter And Year Ended 31St March, 2025.
21 May - Cupid Limited approved audited Q4 and FY25 financial results; appointed internal and secretarial auditors.
-
Board Meeting Outcome for Outcome Of Board Meeting Held On 21 May, 2025.
21 May - Cupid Limited announces audited Q4 and FY25 financial results and appoints internal and secretarial auditors.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Concalls
-
May 2025TranscriptNotesPPT
-
Aug 2024TranscriptNotesPPT
-
Apr 2024TranscriptNotesPPT
-
Jan 2024Transcript PPT
-
Nov 2023TranscriptPPTREC
-
Aug 2023TranscriptPPT
-
Jun 2023Transcript PPT
-
Feb 2023TranscriptPPT
-
Nov 2022Transcript PPT
-
Aug 2022TranscriptPPT
-
Jun 2022TranscriptPPT
-
Feb 2022TranscriptPPT
-
Nov 2021Transcript PPT
-
Aug 2021TranscriptPPT
-
Jun 2021TranscriptPPT
-
Feb 2021TranscriptPPT
-
Nov 2020TranscriptPPT
-
Sep 2020TranscriptPPT
-
Jan 2020TranscriptPPT
-
Nov 2019TranscriptPPT
-
Jul 2019TranscriptPPT
-
Jun 2019TranscriptPPT
-
Feb 2019TranscriptPPT
-
Nov 2018TranscriptPPT
-
Aug 2018TranscriptPPT
-
Feb 2018TranscriptNotesPPT
-
Nov 2017TranscriptPPT
-
Jul 2017TranscriptPPT
-
May 2017TranscriptPPT
-
Nov 2016TranscriptPPT
-
Jul 2016TranscriptPPT
-
May 2016Transcript PPT
Products Offered[1]
The Co. manufactures male condoms, female condoms, water-based lubricant jelly, IVD products such as Pregnancy Test Kits, Covid 19 Antigen Test Kit, HIV Test Kit, Dengue test kits, Malaria antigen test kits, etc.